Clinical Trials Logo

Clinical Trial Summary

A nationwide, cross-sectional study, to determine the prevalence of symptoms of patients in the palliative phase in various care settings will be performed within a set period of two weeks in September 2018 and two weeks in November 2018. The participating settings will be selected by a total of seven coordinators, one for each consortium of palliative care in the Netherlands. To identify common combinations of symptoms and for multidimensional screening the Utrecht Symptom Diary-4 Dimensional (USD-4D) and Utrecht Symptom Diary (USD), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used. The current protocol focuses on the cross-sectional study.


Clinical Trial Description

The Utrecht Symptom Diary-4 dimensional (USD-4D), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used for multidimensional screening and assessment of intensity and prevalence of symptoms. The questionnaire assesses twelve symptoms: pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion. This is measured on a numeric scale from 0 (no complaints) to 10 (worst imaginable or intolerable). The prevalence of symptoms will be described by frequencies, dichotomizing symptom scores in absent (0 on NRS) or present (1 or higher on NRS). Symptom scores of 4 or higher on NRS are considered clinically relevant. There is a possibility to add two more complaints not enlisted and to prioritise the problems which should be addressed first by the HCP. Quality of life is assessed using a (un)well-being measure and the opportunity to score the experienced value of life. Finally, five multidimensional questions will screen for mental capacity ("draagkracht"), the relationship with loved ones and thoughts concerning end of life. These multidimensional questions will be filled out together with the HCP. Therefore the HCP decides beforehand whether those questions will be asked. The USD-4D will be filled out only once by participating patients without follow-up. The patients will be asked to fill out the following characteristics: age, gender, education level, cultural background, living situation, underlying disease, comorbidities, performance score, medication groups and interventions. The estimated time to fill out both questionnaires is fifteen to twenty-five minutes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03665168
Study type Observational
Source University Medical Center Groningen
Contact
Status Completed
Phase
Start date September 1, 2018
Completion date December 1, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT03245658 - The Effect of Cannabis in Pancreatic Cancer Phase 2
Not yet recruiting NCT06328751 - Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service N/A
Recruiting NCT05883696 - Palliative Care Needs Among Elderly People at Emergency Department
Completed NCT01415934 - Statin Discontinuation in Advanced Illness N/A
Recruiting NCT04519632 - Paediatric Palliative Care Pain Management in the Community
Not yet recruiting NCT06110624 - The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
Completed NCT04630743 - Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease N/A
Completed NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life N/A
Not yet recruiting NCT06329856 - Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients in Taiwan
Terminated NCT02581059 - Efficacy of Ginseng for Patients on Regorafenib Phase 2
Terminated NCT04251520 - The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients N/A
Withdrawn NCT06310889 - Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project
Completed NCT05640076 - Effects of a 24/7 Palliative Care Service Integration in a Metropolitan Area on Non-oncologic Patients